Stratos Genomics Inc., a Seattle, WA-based developer of a single-molecule detection process, has raised an additional $2.1m in Series A funding.
Investors include existing shareholders Fisk Ventures and Stratos Group LLC (from which the company spun out in 2007).
Stratos intends to use the funds, which add to August 2010’s $4m financing (read the news), to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics.
Led by CEO Allan Stephan, the company develops a single-molecule detection process that allows accurate, ultra-low-cost whole genome sequencing (Sequencing by Expansion™” – SBX™).
FinSMEs
08/06/2011